Attending Pharmig 2018, AstraZeneca's Karen Capper and GSK's Paul J Newby unveiled details of the Microbiology Modernisation Cross-industry Consortium (MMCC), an initiative that has been in the making...
GSK and 23andMe unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the basis for discovery.
TrialScope, the global leader in clinical trial transparency and compliance solutions, announced that it has been selected by GlaxoSmithKline plc to facilitate clinical trial disclosure and transparency
Syngene International, a leading global contract research services company, announced an R&D agreement with GSK, a science-led global healthcare company. The agreement will focus on the discovery of new drug candidates.